|
Flumazenil
|
DB01205 |
[Fumazenil is an imidazobenzodiazepine derivative and a potent benzodiazepine receptor antagonist that competitively inhibits the activity at the benzodiazepine recognition site on the GABA/benzodiazepine receptor complex, thereby reversing the effects of benzodiazepine on the central nervous system.] |
|
Sparfloxacin
|
DB01208 |
[Sparfloxacin is a fluoroquinolone antibiotic indicated for bacterial infections. Sparfloxacin exerts its antibacterial activity by inhibiting DNA gyrase, a bacterial topoisomerase. DNA gyrase is an essential enzyme which controls DNA topology and assists in DNA replication, repair, deactivation, and transcription.] |
|
D-glyceraldehyde
|
DB02536 |
|
|
Meta-Nitro-Tyrosine
|
DB03867 |
|
|
3-Dehydroquinic Acid
|
DB03868 |
|
|
2-Hydroxy-5-({1-[(4-Methylphenoxy)Methyl]-3-Oxoprop-1-Enyl}Amino)-L-Tyrosine
|
DB02537 |
|
|
Ridogrel
|
DB01207 |
[Ridogrel is a dual action drug useful for the prevention of systemic thrombo-embolism and as an adjunctive agent to thrombolytic therapy in acute myocardial infarction. However, there currently are no clinical indications for preferential use of ridogrel over aspirin.] |
|
2-Allylphenol
|
DB02534 |
|
|
6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine
|
DB03865 |
|
|
Levetiracetam
|
DB01202 |
[Levetiracetam is a drug within the pyrrolidine class that is used to treat various types of seizures stemming from epileptic disorders. It was first approved for use in the United States in 1999 and is structurally and mechanistically unrelated to other anti-epileptic drugs (AEDs).[L8606,L8600,L8615] Levetiracetam possesses a wide therapeutic index[L8615,A185918] and little-to-no potential to produce, or be subject to, pharmacokinetic interactions[L8606,L8600,L8615] - these characteristics make it a desirable choice over other AEDs, a class of drugs notorious for having generally narrow therapeutic indexes and a propensity for involvement in drug interactions.[A185927]] |
|
Prostaglandin G2
|
DB03866 |
[A cyclic endoperoxide intermediate produced by the action of CYCLOOXYGENASE on ARACHIDONIC ACID. It is further converted by a series of specific enzymes to the series 2 prostaglandins. [PubChem]] |
|
Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide
|
DB02535 |
|
|
Rifapentine
|
DB01201 |
[Rifapentine is an antibiotic drug used in the treatment of tuberculosis. It inhibits DNA-dependent RNA polymerase activity in susceptible cells. Specifically, it interacts with bacterial RNA polymerase but does not inhibit the mammalian enzyme.] |
|
Mitoxantrone
|
DB01204 |
[An anthracenedione-derived antineoplastic agent.] |
|
2-O-methyl fucose
|
DB03863 |
|
|
2,4,6-Triaminoquinazoline
|
DB02532 |
|
|
Monothioglycerol
|
DB03864 |
|
|
Nadolol
|
DB01203 |
[Nadolol is a nonselective beta adrenal receptor blocker that is used to lower blood pressure.[L7922,L7925] Nonselective beta adrenal receptor blockers may no longer be first line in the treatment of hypertension as newer generations of beta adrenal receptor blockers have higher selectivity and offer better rates of adverse effects.[A34177]
Nadolol was granted FDA approval on 10 December 1979.[L7922]] |
|
gamma-Aminobutyric acid
|
DB02530 |
[The most common inhibitory neurotransmitter in the central nervous system.] |
|
(2R,3R,4S,5R)-2-acetamido-3,4-dihydroxy-5-hydroxymethyl-piperidine
|
DB03861 |
|
